SCHEMBL667844

SCHEMBL667844

CC(C(=O)O)N(C)C(=O)O.[NaH].[NaH]

nearest known ligand 0.40

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.38
LTA4H P09960 1/20 0.33
SLC7A5 Q01650 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3713869 0.97 TP53 (0.40) TP53LTA4HSLC7A5
SCHEMBL18125942 0.97 TP53 (0.40) TP53LTA4HSLC7A5
SCHEMBL3715388 0.97 TP53 (0.40) TP53LTA4HSLC7A5
SCHEMBL27536530 0.81 TP53 (0.30) TP53
SCHEMBL27500348 0.81 TP53 (0.30) TP53
SCHEMBL29148769 0.81 TP53 (0.36) TP53LTA4HSLC7A5
SCHEMBL12530263 0.78 TP53 (0.38) TP53LTA4HSLC7A5
SCHEMBL11156860 0.78 TP53 (0.38) TP53LTA4HSLC7A5
SCHEMBL11170894 0.78 TP53 (0.38) TP53LTA4HSLC7A5
SCHEMBL22164139 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140155646-A1 PROCESS FOR THE PREPARATION OF A POWDER COMPRISING ONE OR MORE DERIVATIVES OF GLYCINE-N,N DIACETIC ACID AND /OR ONE OR MORE DERIVATIVES OF GLUTAMINE-N,N DIACETIC ACID AND METHYLGLYCINE-N,N DIACETIC ACID TRISODIUM SALT POWDER BASF SE (DE) 2014-06-05 US disclosed
US-8628684-B2 Process for the preparation of a powder comprising one or more derivatives of glycine-N,N diacetic acid and/or one or more derivatives of glutamine-N,N diacetic acid and methylglycine-N,N diacetic acid trisodium salt powder BASF SE (DE) 2014-01-14 US disclosed
US-20120046491-A1 PROCESS FOR THE PREPARATION OF A POWDER COMPRISING ONE OR MORE DERIVATIVES OF GLYCINE-N,N DIACETIC ACID AND /OR ONE OR MORE DERIVATIVES OF GLUTAMINE-N,N DIACETIC ACID AND METHYLGLYCINE-N,N DIACETIC ACID TRISODIUM SALT POWDER BASF SE (DE) 2012-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046491-A1 PROCESS FOR THE PREPARATION OF A POWDER COMPRISING ONE OR MORE DERIVATIVES OF GLYCINE-N,N DIACETIC ACID AND /OR ONE OR MORE DERIVATIVES OF GLUTAMINE-N,N DIACETIC ACID AND METHYLGLYCINE-N,N DIACETIC ACID TRISODIUM SALT POWDER GNMT, GLUL, ASNS TP53 2850/4885LTA4H 4392/4885SLC7A5 44/4885
US-20140155646-A1 PROCESS FOR THE PREPARATION OF A POWDER COMPRISING ONE OR MORE DERIVATIVES OF GLYCINE-N,N DIACETIC ACID AND /OR ONE OR MORE DERIVATIVES OF GLUTAMINE-N,N DIACETIC ACID AND METHYLGLYCINE-N,N DIACETIC ACID TRISODIUM SALT POWDER GNMT, GLUL, ASNS TP53 2986/4885LTA4H 4405/4885SLC7A5 36/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.